Imagion Biosystems Limited (ASX:IBX) (the Company), a Company dedicated to improving healthcare through the earlier detection of cancer, is pleased to share the updated investor presentation.
Chief Executive Officer Robert (Bob) Proulx is conducting an investor roadshow in Sydney, Melbourne and Perth from Monday 9 – Friday 13 September, 2019.
Download the investor presentation.
Imagion Initiates Manufacturing of MagSense® Drug for Phase 2 Clinical Study on HER2+ Breast Cancer
February 19, 2025
MELBOURNE – Imagion Biosystems (Company) (ASX : IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to announce